Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-16

FDA Approved: VYBRIQUE — Original Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved VYBRIQUE (sildenafil citrate) from IBSA Pharma Inc. through an original new drug application, establishing its use for erectile dysfunction in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VYBRIQUE (SILDENAFIL CITRATE)

Snippet

ORIG AP for VYBRIQUE (SILDENAFIL CITRATE)